(Q37914185)

English

Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel

scientific article published on 10 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel (English)

1 reference

Europe PubMed Central

25 August 2017

1 reference

based on heuristic

inferred from title

Gautam Borthakur

10

object named as

Gautam Borthakur

1 reference

Europe PubMed Central

25 August 2017

8

object named as

Mark Litzow

1 reference

Europe PubMed Central

25 August 2017

author name string

Wendy Stock

1

1 reference

Europe PubMed Central

25 August 2017

Dan Douer

2

1 reference

Europe PubMed Central

25 August 2017

Daniel J DeAngelo

3

1 reference

Europe PubMed Central

25 August 2017

Martha Arellano

4

1 reference

Europe PubMed Central

25 August 2017

Anjali Advani

5

1 reference

Europe PubMed Central

25 August 2017

Lloyd Damon

6

1 reference

Europe PubMed Central

25 August 2017

Tibor Kovacsovics

7

1 reference

Europe PubMed Central

25 August 2017

Michael Rytting

9

1 reference

Europe PubMed Central

25 August 2017

Archie Bleyer

11

1 reference

Europe PubMed Central

25 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 August 2011

1 reference

Europe PubMed Central

25 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

25 August 2017

52

1 reference

Europe PubMed Central

25 August 2017

12

1 reference

Europe PubMed Central

25 August 2017

2237-2253

1 reference

Europe PubMed Central

25 August 2017

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Toxicity of E. coli L-asparaginase in man

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Pegaspargase: a review of clinical studies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Predicting asparaginase-associated pancreatitis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Pegaspargase-induced pancreatitis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Toxicity of L-asparaginase in children with advanced leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Effect of L-asparaginase on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Diabetes in patients treated with asparaginase

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Endocrine complications in pediatric patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Dexamethasone induces a heat-stress response that ameliorates the conformational consequences on antithrombin of L-asparaginase treatment.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Cerebral sinovenous thrombosis in children.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Thrombosis and acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Asparaginase revisited

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL stu

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.596963

21 January 2018

Identifiers

10.3109/10428194.2011.596963

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37914185&oldid=1733620066"